Does GUSELKUMAB Cause Injection site mass? 34 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Injection site mass have been filed in association with GUSELKUMAB (TREMFYA). This represents 0.1% of all adverse event reports for GUSELKUMAB.
34
Reports of Injection site mass with GUSELKUMAB
0.1%
of all GUSELKUMAB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Injection site mass From GUSELKUMAB?
Of the 34 reports, 1 (2.9%) required hospitalization.
Is Injection site mass Listed in the Official Label?
Yes, Injection site mass is listed as a known adverse reaction in the official FDA drug label for GUSELKUMAB.
What Other Side Effects Does GUSELKUMAB Cause?
Product dose omission issue (9,267)
Accidental exposure to product (2,941)
Drug ineffective (1,971)
Needle issue (1,933)
Psoriasis (1,817)
Device issue (1,613)
Device malfunction (1,410)
Off label use (1,186)
Product storage error (1,017)
Inappropriate schedule of product administration (830)
What Other Drugs Cause Injection site mass?
EXENATIDE (3,506)
DUPILUMAB (2,243)
GLATIRAMER (2,172)
ETANERCEPT (2,101)
NALTREXONE (1,849)
TIRZEPATIDE (1,386)
LEUPROLIDE (1,359)
DULAGLUTIDE (1,319)
EVOLOCUMAB (1,254)
ADALIMUMAB (915)
Which GUSELKUMAB Alternatives Have Lower Injection site mass Risk?
GUSELKUMAB vs HAIR KERATIN AMINO ACIDS GOLD COMPLEX
GUSELKUMAB vs HALDOL
GUSELKUMAB vs HALOBETASOL
GUSELKUMAB vs HALOPERIDOL
GUSELKUMAB vs HALOPERIDOL DECANOATE